These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24966922)

  • 1. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo.
    Hu GH; Liu H; Lai P; Guo ZF; Xu L; Yao XD; Zheng JH; Liu M; Xu YF
    Int J Clin Exp Pathol; 2014; 7(5):2143-52. PubMed ID: 24966922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.
    Huang QB; Ma X; Zhang X; Liu SW; Ai Q; Shi TP; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Li HZ; Zheng T
    PLoS One; 2013; 8(6):e67294. PubMed ID: 23826258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
    Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
    Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
    Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
    Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dll4 blockade potentiates the anti-tumor effects of VEGF inhibition in renal cell carcinoma patient-derived xenografts.
    Miles KM; Seshadri M; Ciamporcero E; Adelaiye R; Gillard B; Sotomayor P; Attwood K; Shen L; Conroy D; Kuhnert F; Lalani AS; Thurston G; Pili R
    PLoS One; 2014; 9(11):e112371. PubMed ID: 25393540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
    Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
    Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH
    BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination DLL4 with Jagged1-siRNA can enhance inhibition of the proliferation and invasiveness activity of human gastric carcinoma by Notch1/VEGF pathway.
    Sun HW; Wu C; Tan HY; Wang QS
    Hepatogastroenterology; 2012 May; 59(115):924-9. PubMed ID: 22020917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
    Qiu XX; Chen L; Wang CH; Lin ZX; Chen BJ; You N; Chen Y; Wang XF
    World Neurosurg; 2016 Apr; 88():447-458. PubMed ID: 26546995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
    Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
    Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-like ligand 4-notch blockade and tumor radiation response.
    Liu SK; Bham SA; Fokas E; Beech J; Im J; Cho S; Harris AL; Muschel RJ
    J Natl Cancer Inst; 2011 Dec; 103(23):1778-98. PubMed ID: 22010178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling.
    Peng XS; Yang JP; Qiang YY; Sun R; Cao Y; Zheng LS; Peng LX; Lang YH; Mei Y; Li CZ; Meng DF; Liu ZJ; Wang MD; Zhou FJ; Huang BJ; Qian CN
    Mol Cancer Res; 2020 Jun; 18(6):903-912. PubMed ID: 32169891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
    Chen L; Xie Y; Ma X; Zhang Y; Li X; Zhang F; Gao Y; Fan Y; Gu L; Wang L; Zhang X; Fu B
    Mol Carcinog; 2020 Oct; 59(10):1159-1173. PubMed ID: 32794610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
    Yang MH; Chang KJ; Li B; Chen WS
    Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.
    Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J
    World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable silencing of dll4 gene suppresses the growth and metastasis of esophagus cancer cells by attenuating Akt phosphorylation.
    Guo X; Duan Y; Ye X; Hu L; Xu T; Tong L; Yu M
    Oncol Rep; 2018 Jul; 40(1):495-503. PubMed ID: 29749499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication.
    Kunanopparat A; Issara-Amphorn J; Leelahavanichkul A; Sanpavat A; Patumraj S; Tangkijvanich P; Palaga T; Hirankarn N
    World J Gastroenterol; 2018 Sep; 24(34):3861-3870. PubMed ID: 30228780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells.
    Yen WC; Fischer MM; Hynes M; Wu J; Kim E; Beviglia L; Yeung VP; Song X; Kapoun AM; Lewicki J; Gurney A; Simeone DM; Hoey T
    Clin Cancer Res; 2012 Oct; 18(19):5374-86. PubMed ID: 22952347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.